MEGAN BECKER: Open Payments
NPI 1255813788 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 27 payments from 8 companies in 2025. Trend: 2023 $812 · 2024 $1,115 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 11 | $359 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $157 |
| Alkermes, Inc. | 1 | $90 |
| Bausch Health US, LLC | 3 | $59 |
| Lundbeck LLC | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Noven Therapeutics, LLC | 1 | $15 |
Products named: Auvelity, CAPLYTA, ARISTADA, APLENZIN, REXULTI, SPRAVATO, Qelbree, Xelstrym.
Industry payments across IL — which companies pay providers there.
